Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
Identifieur interne : 000771 ( PubMed/Corpus ); précédent : 000770; suivant : 000772Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
Auteurs : Sophie Desmonde ; François T. Eboua ; Karen Malateste ; Fatoumata Dicko ; Didier K. Ekouévi ; Sylvie Ngbeché ; Fla Koueta ; Haby Signate Sy ; Lorna Renner ; Siriatou A. Koumakpai ; Valeriane LeroySource :
- AIDS (London, England) [ 1473-5571 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Africa, Western.
- drug therapy : HIV Infections.
- methods : Antiretroviral Therapy, Highly Active.
- CD4 Lymphocyte Count, Child, Child, Preschool, Female, Humans, Incidence, Male, Risk Factors, Time Factors, Treatment Failure, Viral Load.
Abstract
We described reasons for switching to second-line antiretroviral treatment (ART) and time to switch in HIV-infected children failing first-line ART in West Africa.
DOI: 10.1097/QAD.0000000000000707
PubMed: 26244392
Links to Exploration step
pubmed:26244392Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.</title><author><name sortKey="Desmonde, Sophie" sort="Desmonde, Sophie" uniqKey="Desmonde S" first="Sophie" last="Desmonde">Sophie Desmonde</name><affiliation><nlm:affiliation>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou, Benin. *See composition in Acknowledgements.</nlm:affiliation></affiliation></author><author><name sortKey="Eboua, Francois T" sort="Eboua, Francois T" uniqKey="Eboua F" first="François T" last="Eboua">François T. Eboua</name></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name></author><author><name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouévi">Didier K. Ekouévi</name></author><author><name sortKey="Ngbeche, Sylvie" sort="Ngbeche, Sylvie" uniqKey="Ngbeche S" first="Sylvie" last="Ngbeché">Sylvie Ngbeché</name></author><author><name sortKey="Koueta, Fla" sort="Koueta, Fla" uniqKey="Koueta F" first="Fla" last="Koueta">Fla Koueta</name></author><author><name sortKey="Sy, Haby Signate" sort="Sy, Haby Signate" uniqKey="Sy H" first="Haby Signate" last="Sy">Haby Signate Sy</name></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name></author><author><name sortKey="Koumakpai, Siriatou A" sort="Koumakpai, Siriatou A" uniqKey="Koumakpai S" first="Siriatou A" last="Koumakpai">Siriatou A. Koumakpai</name></author><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26244392</idno><idno type="pmid">26244392</idno><idno type="doi">10.1097/QAD.0000000000000707</idno><idno type="wicri:Area/PubMed/Corpus">000771</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000771</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.</title><author><name sortKey="Desmonde, Sophie" sort="Desmonde, Sophie" uniqKey="Desmonde S" first="Sophie" last="Desmonde">Sophie Desmonde</name><affiliation><nlm:affiliation>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou, Benin. *See composition in Acknowledgements.</nlm:affiliation></affiliation></author><author><name sortKey="Eboua, Francois T" sort="Eboua, Francois T" uniqKey="Eboua F" first="François T" last="Eboua">François T. Eboua</name></author><author><name sortKey="Malateste, Karen" sort="Malateste, Karen" uniqKey="Malateste K" first="Karen" last="Malateste">Karen Malateste</name></author><author><name sortKey="Dicko, Fatoumata" sort="Dicko, Fatoumata" uniqKey="Dicko F" first="Fatoumata" last="Dicko">Fatoumata Dicko</name></author><author><name sortKey="Ekouevi, Didier K" sort="Ekouevi, Didier K" uniqKey="Ekouevi D" first="Didier K" last="Ekouévi">Didier K. Ekouévi</name></author><author><name sortKey="Ngbeche, Sylvie" sort="Ngbeche, Sylvie" uniqKey="Ngbeche S" first="Sylvie" last="Ngbeché">Sylvie Ngbeché</name></author><author><name sortKey="Koueta, Fla" sort="Koueta, Fla" uniqKey="Koueta F" first="Fla" last="Koueta">Fla Koueta</name></author><author><name sortKey="Sy, Haby Signate" sort="Sy, Haby Signate" uniqKey="Sy H" first="Haby Signate" last="Sy">Haby Signate Sy</name></author><author><name sortKey="Renner, Lorna" sort="Renner, Lorna" uniqKey="Renner L" first="Lorna" last="Renner">Lorna Renner</name></author><author><name sortKey="Koumakpai, Siriatou A" sort="Koumakpai, Siriatou A" uniqKey="Koumakpai S" first="Siriatou A" last="Koumakpai">Siriatou A. Koumakpai</name></author><author><name sortKey="Leroy, Valeriane" sort="Leroy, Valeriane" uniqKey="Leroy V" first="Valeriane" last="Leroy">Valeriane Leroy</name></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa, Western</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active (methods)</term><term>CD4 Lymphocyte Count</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Risk Factors</term><term>Time Factors</term><term>Treatment Failure</term><term>Viral Load</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa, Western</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" xml:lang="en"><term>CD4 Lymphocyte Count</term><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Risk Factors</term><term>Time Factors</term><term>Treatment Failure</term><term>Viral Load</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We described reasons for switching to second-line antiretroviral treatment (ART) and time to switch in HIV-infected children failing first-line ART in West Africa.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26244392</PMID><DateCreated><Year>2015</Year><Month>08</Month><Day>06</Day></DateCreated><DateCompleted><Year>2016</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5571</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>AIDS (London, England)</Title><ISOAbbreviation>AIDS</ISOAbbreviation></Journal><ArticleTitle>Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.</ArticleTitle><Pagination><MedlinePgn>1527-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/QAD.0000000000000707</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We described reasons for switching to second-line antiretroviral treatment (ART) and time to switch in HIV-infected children failing first-line ART in West Africa.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included all children aged 15 years or less, starting ART (at least three drugs) in the paediatric IeDEA clinical centres in five West-African countries. We estimated the incidence of switch (at least one a drug class change) within 24 months of ART and associated factors were identified in a multinomial logistic regression. Among children with clinical-immunological failure, we estimated the 24-month probability of switching to a second-line and associated factors, using competing risks. Children who switched to second-line ART following the withdrawal of nelfinavir in 2007 were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 2820 children initiated ART at a median age of 5 years; 144 (5%) were on nelfinavir. At 24-month post-ART initiation, 188 (7%) had switched to second-line. The most frequent reasons were drug stock outs (20%), toxicity (18%), treatment failure (16%) and poor adherence (8%). Over the 24-month follow-up period, 322 (12%) children failed first-line ART after a median time of 7 months. Of these children, 21 (7%) switched to second-line after a median time of 21 weeks in failure. This was associated with older age [subdistribution hazard ratio (sHR) 1.21, 95% confidence interval (95% CI) 1.10-1.33] and longer time on ART (sHR 1.16, 95% CI 1.07-1.25).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Switches for clinical failure were rare and switches after an immunological failure were insufficient. These gaps reveal that it is crucial to advocate for both sustainable access to first-line and alternative regimens to provide adequate roll-out of paediatric ART programmes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Desmonde</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>aInstitut de Santé Publique, d'Epidémiologie et de Développement, Université Bordeaux bInserm, Centre Inserm U897-Epidémiologie-Biostatistique, Bordeaux, France cCHU de Yopougon, Abidjan, Côte d'Ivoire dHopital Gabriel Toure, Bamako, Mali eIeDEA Regional Center, PACCI, CHU de Treichville fCentre pédiatrique de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire gHôpital pédiatrique, CHU Charles de Gaulle, Ouagadougou, Burkina Faso hHôpital d'enfants Albert-Royer, Dakar, Sénégal iKorle Bu Hospital, Accra, Ghana jService pédiatrie CHU National, Cotonou, Benin. *See composition in Acknowledgements.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eboua</LastName><ForeName>François T</ForeName><Initials>FT</Initials></Author><Author ValidYN="Y"><LastName>Malateste</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Dicko</LastName><ForeName>Fatoumata</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ekouévi</LastName><ForeName>Didier K</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Ngbeché</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Koueta</LastName><ForeName>Fla</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Sy</LastName><ForeName>Haby Signate</ForeName><Initials>HS</Initials></Author><Author ValidYN="Y"><LastName>Renner</LastName><ForeName>Lorna</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Koumakpai</LastName><ForeName>Siriatou A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Leroy</LastName><ForeName>Valeriane</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><CollectiveName>IeDEA Pediatric West African Working Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01AI069919</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>AIDS</MedlineTA><NlmUniqueID>8710219</NlmUniqueID><ISSNLinking>0269-9370</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000354" MajorTopicYN="N" Type="Geographic">Africa, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Zannou</LastName><ForeName>Djimon Marcel</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahouada</LastName><ForeName>Carin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akakpo</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahomadegbé</LastName><ForeName>Christelle</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bashi</LastName><ForeName>Jules</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gougounon-Houéto</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azon-Kouanou</LastName><ForeName>Angèle</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Houngbé</LastName><ForeName>Fabien</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sehonou</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koumakpai</LastName><ForeName>Sikiratou</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alihonou</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>d'Almeida</LastName><ForeName>Marcelline</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hodonou</LastName><ForeName>Irvine</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hounhoui</LastName><ForeName>Ghislaine</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sagbo</LastName><ForeName>Gracien</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tossa-Bagnan</LastName><ForeName>Leïla</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adjide</LastName><ForeName>Herman</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drabo</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bognounou</LastName><ForeName>René</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dienderé</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traore</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zoungrana</LastName><ForeName>Lassane</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zerbo</LastName><ForeName>Béatrice</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sawadogo</LastName><ForeName>Adrien Bruno</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zoungrana</LastName><ForeName>Jacques</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Héma</LastName><ForeName>Arsène</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soré</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bado</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tapsoba</LastName><ForeName>Achille</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yé</LastName><ForeName>Diarra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouéta</LastName><ForeName>Fla</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouedraogo</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ouédraogo</LastName><ForeName>Rasmata</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hiembo</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gansonré</LastName><ForeName>Mady</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messou</LastName><ForeName>Eugène</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gnokoro</LastName><ForeName>Joachim Charles</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koné</LastName><ForeName>Mamadou</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouakou</LastName><ForeName>Guillaume Martial</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bosse</LastName><ForeName>Clarisse Amani</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brou</LastName><ForeName>Kouakou</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Assi</LastName><ForeName>Achi Isidore</ForeName><Initials>AI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chenal</LastName><ForeName>Henri</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hawerlander</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soppi</LastName><ForeName>Franck</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minga</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abo</LastName><ForeName>Yao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yoboue</LastName><ForeName>Jean-Michel</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eholié</LastName><ForeName>Serge Paul</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amego</LastName><ForeName>Mensah Deborah Noelly</ForeName><Initials>MD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andavi</LastName><ForeName>Viviane</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diallo</LastName><ForeName>Zelica</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ello</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tanon</LastName><ForeName>Aristophane Koffi</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koule</LastName><ForeName>Serge Olivier</ForeName><Initials>SO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anzan</LastName><ForeName>Koffi Charles</ForeName><Initials>KC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guehi</LastName><ForeName>Calixte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aka</LastName><ForeName>Edmond Addi</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Issouf</LastName><ForeName>Koffi Ladji</ForeName><Initials>KL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouakou</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>N'Gbeche</LastName><ForeName>Marie-Sylvie</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pety</LastName><ForeName>Touré</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avit-Edi</LastName><ForeName>Divine</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouakou</LastName><ForeName>Kouadio</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moh</LastName><ForeName>Magloire</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>Valérie Andoblé</ForeName><Initials>VA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Folquet</LastName><ForeName>Madeleine Amorissani</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dainguy</LastName><ForeName>Marie-Evelyne</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouakou</LastName><ForeName>Cyrille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Méa-Assande</LastName><ForeName>Véronique Tanoh</ForeName><Initials>VT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oka-Berete</LastName><ForeName>Gladys</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zobo</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Acquah</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kokora</LastName><ForeName>Marie-Berthe</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eboua</LastName><ForeName>Tanoh François</ForeName><Initials>TF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Timité-Konan</LastName><ForeName>Marguerite</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahoussou</LastName><ForeName>Lucrèce Diecket</ForeName><Initials>LD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Assouan</LastName><ForeName>Julie Kebé</ForeName><Initials>JK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sami</LastName><ForeName>Mabéa Flora</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouadio</LastName><ForeName>Clémence</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Renner</LastName><ForeName>Lorna</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goka</LastName><ForeName>Bamenla</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welbeck</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sackey</LastName><ForeName>Adziri</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Owiafe</LastName><ForeName>Seth Ntiri</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wejse</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Da Silva</LastName><ForeName>Zacarias José</ForeName><Initials>ZJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paulo</LastName><ForeName>Joao</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Amabelia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>da Silva</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medina</LastName><ForeName>Candida</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliviera-Souto</LastName><ForeName>Ines</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Østergaard</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laursen</LastName><ForeName>Alex</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sodemann</LastName><ForeName>Morten</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aaby</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fomsgaard</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erikstrup</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eugen-Olsen</LastName><ForeName>Jesper</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leuenberger</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hebelamou</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maïga</LastName><ForeName>Moussa Y</ForeName><Initials>MY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diakité</LastName><ForeName>Fatoumata Fofana</ForeName><Initials>FF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalle</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katile</LastName><ForeName>Drissa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traore</LastName><ForeName>Hamar Alassane</ForeName><Initials>HA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minta</LastName><ForeName>Daouda</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cissé</LastName><ForeName>Tidiani</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dembelé</LastName><ForeName>Mamadou</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doumbia</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fomba</LastName><ForeName>Mahamadou</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaya</LastName><ForeName>Assétou Soukho</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traoré</LastName><ForeName>Abdoulaye M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traoré</LastName><ForeName>Hamady</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toure</LastName><ForeName>Amadou Abathina</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dicko</LastName><ForeName>Fatoumata</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sylla</LastName><ForeName>Mariam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berthé</LastName><ForeName>Alima</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traoré</LastName><ForeName>Hadizatou Coulibaly</ForeName><Initials>HC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koïta</LastName><ForeName>Anta</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koné</LastName><ForeName>Niaboula</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>N'Diaye</LastName><ForeName>Clémentine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coulibaly</LastName><ForeName>Safiatou Touré</ForeName><Initials>ST</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traoré</LastName><ForeName>Mamadou</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Traoré</LastName><ForeName>Naïchata</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charurat</LastName><ForeName>Man</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwaghe</LastName><ForeName>Vivian</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ajayi</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alim</LastName><ForeName>Georgina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dapiap</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Igbinoba</LastName><ForeName>Festus</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benson</LastName><ForeName>Okwara</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adebamowo</LastName><ForeName>Clément</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>James</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obaseki</LastName></Investigator><Investigator ValidYN="Y"><LastName>Osakede</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olasode</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seydi</LastName><ForeName>Moussa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sow</LastName><ForeName>Papa Salif</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diop</LastName><ForeName>Bernard</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manga</LastName><ForeName>Noël Magloire</ForeName><Initials>NM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tine</LastName><ForeName>Judicael Malick</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bassabi</LastName><ForeName>Coumba Cissé</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sy</LastName><ForeName>Haby Signate</ForeName><Initials>HS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ba</LastName><ForeName>Abou</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diagne</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dior</LastName><ForeName>Hélène</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faye</LastName><ForeName>Malick</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gueye</LastName><ForeName>Ramatoulaye Diagne</ForeName><Initials>RD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mbaye</LastName><ForeName>Aminata Diack</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patassi</LastName><ForeName>Akessiwe</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotosso</LastName><ForeName>Awèrou</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kariyare</LastName><ForeName>Benjamin Goilibe</ForeName><Initials>BG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gbadamassi</LastName><ForeName>Gafarou</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Komi</LastName><ForeName>Agbo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mensah-Zukong</LastName><ForeName>Kankoé Edem</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pakpame</LastName><ForeName>Pinuwe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawson-Evi</LastName><ForeName>Koko</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atakouma</LastName><ForeName>Yawo</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Takassi</LastName><ForeName>Elom</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Djeha</LastName><ForeName>Améyo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ephoévi-gah</LastName><ForeName>Ayoko</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Djibril</LastName><ForeName>Sherifa El-Hadj</ForeName><Initials>Sel-H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabis</LastName><ForeName>François</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bissagnene</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arrivé</LastName><ForeName>Elise</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coffie</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ekouevi</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaquet</LastName><ForeName>Antoine</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leroy</LastName><ForeName>Valériane</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewden</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sasco</LastName><ForeName>Annie J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Azani</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balestre</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bessekon</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karcher</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonsan</LastName><ForeName>Jules Mahan</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Le Carrou</LastName><ForeName>Jérôme</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenaud</LastName><ForeName>Séverin</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nchot</LastName><ForeName>Célestin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malateste</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yao</LastName><ForeName>Amon Roseamonde</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cissé</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doring</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kouakou</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gneppa</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rabourdin</LastName><ForeName>Elodie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rivenc</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anglaret</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ba</LastName><ForeName>Boubacar</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becquet</LastName><ForeName>Renaud</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soto</LastName><ForeName>Juan Burgos</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Essanin</LastName><ForeName>Jean Bosco</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciaranello</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Datté</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Desmonde</LastName><ForeName>Sophie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diby</LastName><ForeName>Jean-Serge Elvis</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gottlieb</LastName><ForeName>Geoffrey S</ForeName><Initials>GS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horo</LastName><ForeName>Apollinaire Gninlgninrin</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jesson</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kangah</LastName><ForeName>Serge N'zoré</ForeName><Initials>SN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meless</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mounkaila-Harouna</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ndondoki</LastName><ForeName>Camille</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shiboski</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tchounga</LastName><ForeName>Boris</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiébaut</LastName><ForeName>Rodolphe</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wandeler</LastName><ForeName>Gilles</ForeName><Initials>G</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26244392</ArticleId><ArticleId IdType="doi">10.1097/QAD.0000000000000707</ArticleId><ArticleId IdType="pii">00002030-201507310-00013</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000771 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000771 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26244392
|texte= Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26244392" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |